Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure (Q59647597)
Jump to navigation
Jump to search
scientific article published on 02 March 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure |
scientific article published on 02 March 2011 |
Statements
Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure (English)
Wei Gao
Peter G Kelley